← All stocks

AtriCure, Inc.

ATRC Net selling

CIK 0001323885 #1900 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$4.10M

$608.69K on a plan · $1.32M straight out of an exercise

Sold at will

$2.17M

11 of 16 sales

Net

−$4.10M

−$2.17M against sales at will

By person

16 insiders · 17 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

WEHRWEIN SVEN

Director

—

$1.32M (3) scheduled

−$1.32M

40,518

0.0797%

$2.20M

+39.8%

Privitera Salvatore

Chief Technical Officer

—

$608.69K (2) scheduled

−$608.69K

147,264

0.2895%

$7.98M

+41.6%

Doraiswamy Vinayak

Chief Scientific Officer

—

$523.08K (3)

−$523.08K

86,511

0.1701%

$4.69M

+44.7%

Dahlquist Karl S.

Chief Legal Officer

—

$458.10K (1)

−$458.10K

87,319

0.1717%

$4.73M

+69.0%

Noznesky Justin J

Chief Mktg & Strategy Officer

—

$432.50K (2)

−$432.50K

100,219

0.1970%

$5.43M

+40.6%

GROVES REGINA E

Director

—

$288.07K (1)

−$288.07K

34,546

0.0679%

$1.87M

+12.3%

Yuen Maggie

Director

—

$241.63K (2)

−$241.63K

14,015

0.0276%

$759.89K

+56.2%

Prange Karen

Director

—

$224.23K (2)

−$224.23K

22,809

0.0448%

$1.24M

−4.7%

CARREL MICHAEL H

President, CEO, & Director

—

774,434

1.52%

$41.99M

+18.6%

Seith Douglas J

Chief Operating Officer

—

229,867

0.4519%

$12.46M

+49.0%

Wirick Angela L

Chief Financial Officer

—

204,893

0.4028%

$11.11M

+47.3%

WHITE ROBERT S.

Director

—

128,318

0.2523%

$6.96M

+32.6%

JOHNSON B KRISTINE

Director

—

55,954

0.1100%

$3.03M

+26.0%

Yount Deborah Lee

Chief Human Resources Officer

—

45,578

0.0896%

$2.47M

+6.8%

Telman Deborah H

Director

—

28,328

0.0557%

$1.54M

+68.8%

Nachman Shlomo

Director

—

24,655

0.0485%

$1.34M

+88.1%

Individual transactions

Insider

Date

Role

Action

Price

Amount

WEHRWEIN SVEN

28 Jul 2026

Director

Sold after exercise

25,000

$37.84

$946.00K

WEHRWEIN SVEN

25 Nov 2025

Director

Sold after exercise

4,967

$38.00

$188.75K

WEHRWEIN SVEN

24 Nov 2025

Director

Sold after exercise

5,033

$37.32

$187.83K

Show all 17 transactions →

What was left out

Form 4 filings counted 41

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 3

Sales at will 11

Transactions with no price 0

Shares from compensation/vesting 775,313

History held since 14 Sep 2016